RhumbLine Advisers’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2.02M | Sell |
|
|||||
|
2020
Q4 | $924K | Buy |
|
|||||
|
2020
Q3 | $209K | Sell |
|
|||||
|
2020
Q2 | $314K | Sell |
|
|||||
|
2020
Q1 | $135K | Buy |
|
|||||
|
2019
Q4 | $264K | Buy |
|
|||||
|
2019
Q3 | $222K | Buy |
|
|||||
|
2019
Q2 | $317K | Buy |
|
|||||
|
2019
Q1 | $648K | Sell |
|
|||||
|
2018
Q4 | $452K | Buy |
|
|||||
|
2018
Q3 | $476K | Buy |
|
|||||
|
2018
Q2 | $534K | Buy |
|
|||||
|
2018
Q1 | $556K | Buy |
|
|||||
|
2017
Q4 | $646K | Sell |
|
|||||
|
2017
Q3 | $1.42M | Buy |
|
|||||
|
2017
Q2 | $1.03M | Buy |
|
|||||
|
2017
Q1 | $1.22M | Buy |
|
|||||
|
2016
Q4 | $1.65M | Buy |
|
|||||
|
2016
Q3 | $1.71M | Buy |
|
|||||
|
2016
Q2 | $1.31M | Buy |
|
|||||
|
2016
Q1 | $930K | Buy |
|
|||||
|
2015
Q4 | $907K | Buy |
|
|||||
|
2015
Q3 | $296K | Buy |
|
|||||
|
2015
Q2 | $461K | Sell |
|
|||||
|
2015
Q1 | $426K | Buy |
|
|||||
|
2014
Q4 | $378K | Buy |
|
|||||
|
2014
Q3 | $150K | Hold |
|
|||||
|
2014
Q2 | $199K | Buy |
|